+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

Tyrosine Kinase Inhibitors - Global Strategic Business Report - Product Thumbnail Image

Tyrosine Kinase Inhibitors - Global Strategic Business Report

  • Report
  • September 2025
  • 290 Pages
  • Global
From
Preeclampsia Drugs Market Report 2025 - Product Thumbnail Image

Preeclampsia Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Viral Vector Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Viral Vector Collaboration and Licensing Deals 2016-2025

  • Report
  • May 2025
  • 250 Pages
  • Global
From
Fibrotic Diseases Treatment Market - Global Forecast 2025-2030 - Product Thumbnail Image

Fibrotic Diseases Treatment Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 196 Pages
  • Global
From
From
Hepatitis B Virus (HBV) Market Report 2025 - Product Thumbnail Image

Hepatitis B Virus (HBV) Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Inhaled Antibiotics Market Report 2025 - Product Thumbnail Image

Inhaled Antibiotics Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Antibiotics Market Report 2025 - Product Thumbnail Image

Antibiotics Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Pulmonary Embolism Market Report 2025 - Product Thumbnail Image

Pulmonary Embolism Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
Cardiovascular Drugs - Global Strategic Business Report - Product Thumbnail Image

Cardiovascular Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 413 Pages
  • Global
From
Condyloma - Pipeline Insight, 2025 - Product Thumbnail Image

Condyloma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Angina Pectoris Drugs - Global Strategic Business Report - Product Thumbnail Image

Angina Pectoris Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 196 Pages
  • Global
From
Cardiotonic Agents - Global Strategic Business Report - Product Thumbnail Image

Cardiotonic Agents - Global Strategic Business Report

  • Report
  • September 2025
  • 568 Pages
  • Global
From
From
Viral Hepatitis Market Report 2025 - Product Thumbnail Image

Viral Hepatitis Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Cystitis- Pipeline Insight, 2025 - Product Thumbnail Image

Cystitis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Loading Indicator